Education
About Us
Working with TipRanks
Follow Us
Bio-Gene Technology Ltd. (AU:BGT)
ASX:BGT
BGT Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.03 - AU$0.09
Previous CloseN/A
Volume38.03K
Average Volume (3M)1.28M
Market Cap
AU$6.64M
Enterprise ValueN/A
Total Cash (Recent Filing)AU$5.31M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta1.04
Next Earnings
Aug 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding201,361,570
10 Day Avg. Volume98,287
30 Day Avg. Volume1,276,656
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)16.38
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Bio-Gene Technology Ltd. News
PremiumCompany Announcements
Bio-Gene Technology Advances in Natural Insecticide Development
PremiumCompany Announcements
Bio-Gene Technology Announces Investor Webinar on Strategic Developments
PremiumCompany Announcements
Bio-Gene Secures A$3.0M in U.S. Defense Grants for Insecticide Development
PremiumCompany Announcements
Bio-Gene Technology Ends 2.5 Million Securities
PremiumCompany Announcements
Bio-Gene Technology Announces Successful AGM Resolutions
PremiumCompany Announcements
Bio-Gene Technology Eyes Growth in Bio-Insecticide Market
PremiumCompany Announcements
Bio-Gene Technology Strengthens Market Position with Flavocide Progress---
BGT FAQ
What was Bio-Gene Technology Ltd.’s price range in the past 12 months?
Bio-Gene Technology Ltd. lowest share price was AU$0.03 and its highest was AU$0.09 in the past 12 months.
What is Bio-Gene Technology Ltd.’s market cap?
Bio-Gene Technology Ltd.’s market cap is AU$6.64M.
When is Bio-Gene Technology Ltd.’s upcoming earnings report date?
Bio-Gene Technology Ltd.’s upcoming earnings report date is Aug 21, 2025 which is in 169 days.
How were Bio-Gene Technology Ltd.’s earnings last quarter?
Bio-Gene Technology Ltd. released its earnings results on Feb 20, 2025. The company reported -AU$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.007.
Is Bio-Gene Technology Ltd. overvalued?
According to Wall Street analysts Bio-Gene Technology Ltd.’s price is currently Overvalued.
Does Bio-Gene Technology Ltd. pay dividends?
Bio-Gene Technology Ltd. does not currently pay dividends.
What is Bio-Gene Technology Ltd.’s EPS estimate?
Bio-Gene Technology Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bio-Gene Technology Ltd. have?
Bio-Gene Technology Ltd. has 201,361,570 shares outstanding.
What happened to Bio-Gene Technology Ltd.’s price movement after its last earnings report?
Bio-Gene Technology Ltd. reported an EPS of -AU$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 33.333%.
Which hedge fund is a major shareholder of Bio-Gene Technology Ltd.?
Currently, no hedge funds are holding shares in AU:BGT
---
Bio-Gene Technology Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:BGT Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.04%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-56.48%
Trailing 12-Months
Company Description
Bio-Gene Technology Ltd.
Bio-Gene Technology Ltd is an Australian biotechnology company engaged in the development and commercialization of insecticide products. It develops a patent protected product platform based on a naturally occurring class of chemicals known as beta-triketones. Its product includes Qcide and Flavocid. Its target applications include agriculture, public health, and consumer and animal health. The firm operates in one business segment namely the conduct of research and development activities in the discovery of novel insecticides.
---
Technical Analysis
Opthea Limited
―
Imugene Limited
―
Nanosonics Limited
―
Telix Pharmaceuticals Ltd.
―
Cyclopharm Limited
―
---